What if we call them “self-care promises” instead of resolutions?
Heart Sisters
JANUARY 5, 2025
Why are 80% of New Year’s resolutions abandoned by the second week of February?
Heart Sisters
JANUARY 5, 2025
Why are 80% of New Year’s resolutions abandoned by the second week of February?
Frontiers in Cardiovascular Medicine
JANUARY 5, 2025
Obesity is one of the major global health concerns of the 21st century, associated with many comorbidities such as type 2 diabetes mellitus (T2DM), metabolic dysfunction-associated steatotic liver disease, and early and aggressive atherosclerotic cardiovascular disease, which is the leading cause of death worldwide. Bile acids (BAs) and incretins are gut hormones involved in digestion and absorption of fatty acids, and insulin secretion, respectively.
HeartRhythm
JANUARY 5, 2025
Electrophysiological study (EPS) remains controversial for risk stratification in asymptomatic patients with Brugada syndrome (BrS) (1-3). This multicentre study aimed to evaluate the life-threatening event rate in asymptomatic patients with spontaneous type 1 BrS electrocardiographic (ECG) pattern undergoing EPS and its potential role in risk stratification.
Cardiovascular Diabetology
JANUARY 5, 2025
The stress hyperglycemia ratio (SHR) has recently gained attention as a marker for acute hyperglycemia, which has been linked to adverse clinical outcomes. However, its independent role in the development of t.
HCPLive
JANUARY 5, 2025
Schultz discussed the SCtalk trial and its findings at ASH 2024.
Cardiovascular Diabetology
JANUARY 5, 2025
Inflammatory diseases impair the reparative properties of endothelial progenitor cells (EPC); however, the involvement of diabetes in EPC dysfunction associated with myocardial infarction (MI) remains unknown.
HCPLive
JANUARY 5, 2025
Our Endocrinology Month in Review for December 2024 highlights recent headlines in diabetes and endocrinology and 4 new episodes of Diabetes Dialogue.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Frontiers in Cardiovascular Medicine
JANUARY 5, 2025
IntroductionVericiguat, an oral stimulator of soluble guanylate cyclase, reduces cardiovascular mortality and hospitalisations in patients with heart failure (HF) and reduced ejection fraction, as demonstrated in the VICTORIA trial. This study assessed the real-world use of vericiguat.Material and methodsThis cross-sectional, prospective and multicenter registry (VERISEC) included 776 patients from 43 centres in Spain between December 2022 and October 2023.
Dr. Smith's ECG Blog
JANUARY 5, 2025
Written by Willy Frick A man in his 60s with hypertension and prior stroke presented with three days of crushing chest pain. He reported intermittent chest pain for the last few months, but never lasting this long. He described it as substernal with radiation into the right arm. With all of this information, we can feel reasonably confident even before looking at the ECG that we are dealing with OMI.
Frontiers in Cardiovascular Medicine
JANUARY 5, 2025
Fusarium, a genus of soil and vegetation-based fungi, is a rare cause of infections in immunocompromised individuals, including transplant recipients. In this case, we describe successful treatment of Fusarium falciforme mediastinitis in the recipient of an orthotopic heart transplant. Treatment included multiple courses of combination antibiotic and antifungal therapy several surgical debridements, continuous mediastinal irrigation with antifungal agents, and staged closure with an omental flap
Journal of Cardiovascular Electrophysiology
JANUARY 5, 2025
ABSTRACT Introduction Epicardial adipose tissue (EAT) is often associated with atrial fibrosis, and both can provide the substrate for atrial fibrillation (AF). However, most AF patients have no evidence of left atrial (LA) fibrosis based on bipolar voltage mapping. We determined whether EAT differs in AF patients without LA fibrosis compared to matched controls without AF.
Let's personalize your content